A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : NDMM

Search Conditions:
Search Keyword : NDMM
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: NDMM
Appearance Frequency: 93 time(s)
Long forms: 8

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
newly diagnosed multiple myeloma
(56 times)
Hematology
(31 times)
OS (19 times)
PFS (19 times)
ASCT (10 times)
2011 Update on risk stratification and treatment of newly diagnosed multiple myeloma.
newly diagnosed MM
(19 times)
Neoplasms
(8 times)
MM (16 times)
PFS (6 times)
RRMM (5 times)
2014 Impact of C-Myc gene-related aberrations in newly diagnosed myeloma with bortezomib/dexamethasone therapy.
N-nitroso-2,6-dimethylmorpholine
(9 times)
Neoplasms
(6 times)
HPOP (5 times)
BHP (2 times)
PCB (2 times)
1976 Common metabolites of N-nitroso-2,6-dimethylomorpholine and N-nitroso-bis(2-oxopropyl)amine in the Syrian hamster.
newly diagnosed symptomatic MM
(3 times)
Hematologic Neoplasms
(2 times)
MM (3 times)
MGUS (2 times)
BMP (1 time)
2014 Polyclonal serum IgM level identifies a subgroup of multiple myeloma patients with low-risk clinicobiological features and superior survival.
newly diagnosed symptomatic multiple myeloma
(3 times)
Hematologic Neoplasms
(1 time)
CR (1 time)
EMP (1 time)
ETP (1 time)
2015 Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myeloma.
newly diagnosed MM patients
(1 time)
Hematology
(1 time)
CNA (1 time)
HRs (1 time)
MM (1 time)
2018 Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients.
newly diagnosed myeloma patients
(1 time)
Hematology
(1 time)
FISH (1 time)
HCT (1 time)
ORR (1 time)
2018 Treatment patterns and clinical outcomes in high-risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi-center retrospective study.
newly-diagnosed patients with symptomatic myeloma
(1 time)
Hematologic Neoplasms
(1 time)
ICAM-1 (1 time)
MGUS (1 time)
MM (1 time)
2016 Increased circulating VCAM-1 correlates with advanced disease and poor survival in patients with multiple myeloma: reduction by post-bortezomib and lenalidomide treatment.